# Micronized dHACM Injectable for the Treatment of Achille Tendonitis

> **NCT03414255** · PHASE3 · COMPLETED · sponsor: **MiMedx Group, Inc.** · enrollment: 146 (actual)

## Conditions studied

- Tendonitis;Achilles

## Interventions

- **BIOLOGICAL:** Micronized DHACM
- **DRUG:** Saline Injection

## Key facts

- **NCT ID:** NCT03414255
- **Lead sponsor:** MiMedx Group, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-09
- **Primary completion:** 2021-03-30
- **Final completion:** 2021-03-30
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2022-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03414255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03414255, "Micronized dHACM Injectable for the Treatment of Achille Tendonitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03414255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*